Mithridion, the University of Wisconsin-Madison spinoff developing a drug for people with Alzheimer's disease, has closed its first round of financing with $1.6 million that will go toward buying lab equipment, hiring scientists and developing drug candidates....
Third Wave Technologies is appointing more new top management in the wake of its CEO transition, according to a press release....
Madison biotech firm Third Wave Technologies said on Monday that rival Stratagene Corporation has posted a $21 million bond to pay damages and legal fees in a patent case....
Columnist Michael Rosen takes a look at the latest numbers from Burrill & Co. on the state of biotech financing. The results? Those that did well had deep-pocketed partners....
Wisconsin has some catching up to do even among Midwestern states when it comes to health-care venture capital investment, according to the latest Midwest Health Care Venture Investment Report....
Wisconsin has earned another national mention as a "biotech hotspot," this time in e-mail newsletter FierceBiotech....
Biofuels such as ethanol are in vogue these days, thanks to record oil prices and the gnawing realization that our national security would be enhanced by producing more energy at home....
Wisconsin's secretary of revenue, Michael Morgan, said during a visit to Sheboygan that the region could be a player in Wisconsin's biotech industry....
Fortune Magazine's list of the 100 best companies to work for are one way to value the impact of the biotech and pharma industries....
The Biomedical Technology Alliance, a group of investors, scientists and politicians in southeast Wisconsin, said in its 2005 annual report that it is creating a roadmap for a biotechnology campus and other infrastructure in the area....